Related Experiment Video
Updated: Oct 20, 2025
09:30
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
3.8K
Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment
Megan E McMahon1, Alexander Abbott2, Yelizaveta Babayan3
1Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA. megan.mcmahon@pfizer.com.
The AAPS Journal
|September 16, 2021
Summary
The IQ Consortium reviewed ICH stability guidelines, recommending a holistic, risk-based approach. This integrates predictive tools and prior knowledge for enhanced stability data packages and regulatory submissions.
Area of Science:
- Pharmaceutical Science
- Regulatory Science
- Drug Development
Background:
- ICH stability guidelines require updates to incorporate modern scientific advancements.
- Current guidelines may not fully leverage risk-based predictive stability tools.
- The IQ Consortium identified a need for harmonized, science-based stability strategies.
Purpose of the Study:
- To review and propose revisions for ICH stability guidelines (Q1A-E, Q5C).
- To integrate science- and risk-based approaches into stability assessments.
- To align stability strategies with ICH Q8-12 principles.
Main Methods:
- Comprehensive review of existing ICH stability guidelines.
- Analysis of current risk-based predictive stability tools and strategies.
- Development of recommendations for guideline clarification and amendment.
Main Results:
- Identification of areas for guideline improvement.
- Proposal for a holistic approach to stability understanding.
- Expansion of the concept for core stability data packages.
Conclusions:
- Revised ICH guidelines should embrace a holistic, risk-based stability strategy.
- Integration of predictive tools and prior knowledge enhances stability assessment.
- Updated guidelines will support more robust regulatory submissions and post-approval change management.
Keywords:
ICH Q1ICH Q5CRisk-based predictive stabilityScience- and risk-based stabilityStabilityStability risk assessmentMore Related Videos
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
201
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201
01:18Guidelines and Strategies for Safe Computer Charting
1.1K
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Maintain Confidentiality and Security:
1.1K
01:16Drug Product Stability
30
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
30
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
34
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
34
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
29
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
29
01:05Quality Control
460
Quality control is one of the three cyclical quality assurance activities that help keep a system under statistical control. Typical quality control activities include creating quality control charts, conducting proficiency testing, and documenting and archiving results.
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
460